AbbVie (ABBV) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 03/25/24
NIMML Institute's TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie's Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13Business Wire • 03/25/24
Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in AestheticsPRNewsWire • 03/25/24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesPRNewsWire • 03/25/24
Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVieSeeking Alpha • 03/24/24
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer PatientsPRNewsWire • 03/22/24
AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 03/14/24
February's Dividend Portfolio Update Sets New Record - 100 Holdings, 19 Strategic BuysSeeking Alpha • 03/13/24
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key TestInvestors Business Daily • 03/11/24